COVID-19 Articles & Analysis

BOSTON, Nov. 6, 2020 /PRNewswire/ -- Empatica has been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to deploy a wearable and algorithm that enable the early and pre-symptomatic detection of COVID-19. The project's focus is on protecting the health of the general population by preventing outbreaks via early detection and alerting. Empatica's Aura algorithm gives a ...

By Empatica Inc.

AIS with collaboration with Johnson & Johnson Institute has launched a special website dedicated to internal and external content to help healthcare workers keep up on the latest news on COVID-19. The site features: Webinars presented by physicians and leaders in the battle against COVID-19 The New Normal in Elective Surgery Thoracic Surgery on the Frontline of COVID-19 Managing ...

By Auris Health, Inc.

Dear Royal Eijkelkamp customers and relations, Since we started inventing and developing solutions for soil and water related projects in 1911, we have experienced and conquered a lot as a company. At the moment we are experiencing the effects of COVID-19 together with the world. We would like to let you know that our experienced team works for you both from the headquarters in Giesbeek ...

By Royal Eijkelkamp

A non-invasive test for COVID-19 with instant results would be a gamechanger in the efforts against COVID-19. Breath analysis shows a great potential for a rapid, non-invasive detection of COVID-19 infections. Follow our journey around the world, where we shine a light on current research projects where IONICON PTR-TOF instruments are deployed fighting this global pandemic by testing breath for ...

By Ionicon Analytik Ges.m.b.H.

Elkton, Maryland- Micropore is proud to announce the continued support of portable ventilators manufactured by Thornhill Medical for the U.S. Marines, along with Canada’s civilian use for the COVID-19 Pandemic. On March 31, 2020, Canadian Prime Minister Justin Trudeau and Federal Minister of Innovation, Science, and Industry Navdeep Bains announced that Toronto-based Thornhill Medical, a ...

By SpiraLith Brand of Micropore, Inc.

Biolingus IP II GmbH and the CHA Vaccine Institute Co., Ltd., with support from the Korean biotech company PanGen Biotech Inc., will collaborate to develop a sublingual vaccine for COVID. The project has received research funding from The Research Investment for Global Health Technology Fund (The RIGHT Fund). The RIGHT Fund is a Public-Private Partnership (PPP) funding agency between the ...

By BioLingus AG

BOSTON, June 19, 2020 /PRNewswire/ -- Digital healthcare company Empatica announces a pioneering new partnership with the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), to validate an early warning system for COVID-19 and other respiratory ...

By Empatica Inc.

After months of preparation, Notitia Biotechnologies Company (Notitia) announced that its COVID-19 Phase 2 study (COVGUT20) for NBT-NM108 has been given support by the Food and Drug Administration (FDA) to expand its study population to all symptomatic COVID-19 patients. "Previously, our trial focused on COVID-19 patients with type 2 diabetes and prediabetes. Now with this timely expansion to ...

By Notitia Biotechnologies

Kephera Diagnostics has launched a new study aimed at collecting blood samples from volunteers at least 18 years of age who have been confirmed positive for COVID-19, for use in development of an antibody test for the virus. The new test will determine whether symptomatic as well as asymptomatic individuals have been infected with the virus that causes COVID-19 by detecting antibodies to ...

By Kephera Diagnostics, LLC

CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), today announced the availability of three over-the-counter COVID-19 testing options in stores and online. The tests include the Ellume COVID-19 Home Test, the Abbott BinaxNOW COVID-19 Antigen Self Test and the Pixel by Labcorp PCR Test Home Collection Kit. All three tests have received FDA Emergency Use Authorization (EUA), do not ...

By Ellume Limited

tiakis Biotech AG (formerly Proteo Biotech AG) has announced that the German BMBF has selected the Company to conduct a clinical phase 1b/2 trial to develop its investigational medical product Tiprelestat as a potential therapeutic for COVID-19. The aim of the clinical trial is to assess Tiprelestat’s efficacy to attenuate severe disease progression of COVID-19. The Company expects the ...

By tiakis BIOTECH AG

Efforts to develop a quick and non-invasive breath test for the presence of COVID-19 are underway in Vancouver, British Columbia. Imspex’s BreathSpec® is one of a battery of tests that are being used by Dr Renelle Myers and her Vancouver Coastal Health team in their work to develop a breath test that identifies the possible presence of COVID-19 in people who are showing minimal symptoms ...

By Imspex Diagnostics Ltd.

Peer-reviewed resultsfrom the Adaptive COVID-19 Treatment Trial (ACTT-2) published in the New England Journal of Medicine showed that baricitinib in combination with remdesivir reduces recovery time, improves clinical status and demonstrates a trend towards a decrease in mortality in hospitalised COVID-19 patients with pneumonia. Those who took both drugs had a median time to recovery of seven ...

By Benevolent

Ellume Founder, CEO and Managing Director Dr Sean Parsons spoke with Peta Credlin on Sky News’ Credlin program about how Ellume’s range of COVID-19 tests are being sold in the U.S. to support efforts to combat the spread of COVID-19 within the community. To see video, please click here Ellume CEO Dr Sean Parsons says the federal government lacks a “forward-thinking ...

By Ellume Limited

AZOVA Inc., creator of the world’s most comprehensive digital health network for COVID-19 testing and vaccination management, and Ellume, the company to bring the first non-prescription over-the-counter COVID-19 home test to market, today announced an official partnership with Alaska Airlines to provide a convenient, at-home rapid testing solution for its passengers. The Ellume COVID-19 ...

By Ellume Limited

The latest data published in Eli Lilly’s Phase 3 randomised, double-blind, placebo-controlled study (COV-BARRIER) shows the largest clinical effect reported to date for a reduction in mortality in the COVID-19 patient population. ‍ Early in the pandemic, BenevolentAI researchers identified Baricitinib as a potential treatment for COVID-19 and published the hypothesis in The Lancet ...

By Benevolent

AbCellera (Nasdaq: ABCL) today announced that bamlanivimab (LY-CoV555) 700 mg, a human antibody discovered by AbCellera and developed with Eli Lilly and Company (Lilly), and etesevimab 1400 mg (LY-CoV16) together reduced COVID-19-related hospitalizations and deaths by 87% in high-risk patients recently diagnosed with COVID-19. These results mark the second positive Phase 3 trial readout for ...

By AbCellera Biologics Inc.

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the following statement from Douglas Bryant, Quidel’s President and CEO, regarding Quidel’s ongoing efforts to evaluate COVID-19 mutations and confirm that its antigen tests continue to detect COVID-19 ...

By Quidel Corporation

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company with a track record of more than 100 years and a recognized leader in the development and production of plasma-derived medicines, today announced it has begun identifying, screening and selecting volunteer donors who have recovered from COVID-19 to donate their plasma in select U.S. cities. The plasma will be used to produce ...

By Grifols International, S.A.

IAIA members were recently able to study the results of the second survey on “Impact of COVID-19 on Impact Assessment,” which was done 29 July – 6 August 2020. This survey has resulted in some data that are troubling for the practice of impact assessment (IA), and may require a focused examination by IAIA and its members. The survey had 700 respondents from across the world. One ...

By International Association for Impact Assessment (IAIA)